XML 55 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Cash flows from operating activities:    
Net income $ 24,332,603 $ 8,962,894
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 2,366,411 2,270,895
Stock-based compensation expense 805,782 788,326
Deferred income taxes (357,081) (269,149)
Provision for inventory 147,693 229,885
Tax benefit from exercise of stock options (6,825,828) (7,596)
Changes in operating assets and liabilities:    
Accounts receivable (191,088) 1,796,522
Inventories (3,030,077) (2,324,269)
Prepaid expenses, other current and long-term assets (10,624) 703,303
Long-term deposits and other   16,998
Accounts payable (943,169) 878,228
Accrued expenses (749,411) (1,270,885)
Deferred revenue (2,140,902) (1,430,484)
Income taxes payable 7,014,770 (440,210)
Other long-term liabilities (99,980) (271,532)
Net cash provided by operating activities 20,319,099 9,632,926
Cash flows from investing activities:    
Proceeds from sale of assets   246,785
Purchase of property and equipment (677,358) (109,871)
Net cash provided by (used in) investing activities (677,358) 136,914
Cash flows from financing activities:    
Proceeds from exercise of stock options 1,361,805 1,127,875
Tax benefit from exercise of stock options 6,825,828 7,596
Minimum tax withholding on share based awards (6,348,900)  
Principal payments on debt   (800,000)
Net cash provided by financing activities 1,838,733 335,471
Exchange rate impact on cash 65,928 (32,329)
Increase in cash and cash equivalents 21,546,402 10,072,982
Cash and cash equivalents at beginning of period 63,333,160 44,067,477
Cash and cash equivalents at end of period $ 84,879,562 $ 54,140,459